Polyethylene Glycol 3350 in the Treatment of Chronic Idiopathic Constipation: Post hoc Analysis Using FDA Endpoints.

Can J Gastroenterol Hepatol · 2022 · PMC9481403 · PMID 36120087

Europe PMC DOI

hedged sentence

0.1380

closest p · 2.8× alpha

0.1380

boldest claim

The sentences

did not reach statistical significanceP =0.138not close (p > 0.1)

Overall, PEG 3350-treated patients used fewer tablets of rescue medication (bisacodyl) on average than placebo-treated patients; however, this difference (2.85 versus 3.90 tablets per week, respectively) did not reach statistical significance ( P =0.138).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.